Takeda Pharmaceutical Company Limited et al v. Cadila Healthcare Ltd. et al



 
SummaryLawsuit
Summary
 
Court DocumentsCourt
Documents
 
Docket TextDocket
Text
 
Lawsuit Tracker™Lawsuit
Tracker™
 
Docket TextRelated
Cases
 

Docket Text Information

This may not be the most complete up-to-date docket information.
For daily updates on this case, sign-up for a Lawsuit Tracker.


Date # Docket Text
1/21/2011 3 NOTICE OF CASE ASSIGNMENT to Judge Denise L. Cote. Judge Unassigned is no longer assigned to the case. (sjo) (Entered: 01/21/2011)
1/21/2011 Magistrate Judge Ronald L. Ellis is so designated. (sjo) (Entered: 01/21/2011)
1/21/2011 CASE ACCEPTED AS SIMILAR. Create association to 1:10-cv-06679-DLC. Notice of Assignment to follow. (sjo) (Entered: 01/21/2011)
1/19/2011 Mailed notice to Commissioner of Patents and Trademarks to report the filing of this action. (rdz) (Entered: 01/19/2011)
1/14/2011 2 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Takeda America Holdings, Inc., Takeda Pharmaceutical Company Limited as Corporate Parent. Document filed by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals North America, Inc..(rdz) (Entered: 01/19/2011)
1/14/2011 1
1/14/2011 SUMMONS ISSUED as to Cadila Healthcare Ltd., Zydus Pharmaceuticals USA, Inc.. (rdz) (Entered: 01/19/2011)
1/14/2011 CASE REFERRED TO Judge Denise L. Cote as possibly similar to 10-cv-6679. (rdz) (Entered: 01/19/2011)
1/14/2011 Case Designated ECF. (rdz) (Entered: 01/19/2011)


Home   |   About   |   Lawsuits   |   Register   |   Login   |   Terms of Use   |   Privacy Policy   |   Sitemap   |   RSS Feed   |   Contact

© Copyright 2008-2013 RFC Express — All Rights Reserved — Presented By Intellectual Property Today

RFC Express provides access to public lawsuit filings retrieved from the U.S. Federal District Courts.
These lawsuits, and associated information should not be considered findings of fact or liability. Nor do they reflect the views of RFC Express or any of its employees.

extended validation certificate